TABLE 3.
Construct (Etv1 unless specified otherwise) | Description/mutation | Kdapp1 (×10−10 m)a | Kdapp1-fold inhibitionb | Kdapp2 (× 10−10 m)a | Kdapp2-fold inhibitionb |
---|---|---|---|---|---|
WT | Wild type Ets domain | 2.7 ± 0.28 | 1 | 5.9 ± 1.5 | 1 |
Y329S-P427S | PCR mutant Ets domain | 2.5 ± 0.26 | 0.9 | 3.1 ± 0.6 | 0.5 |
K379A | DNA backbone contact | NA | NA | ||
D387A | DNA base contact | 1.7 ± 0.2 | 0.6 | 1.9 ± 0.3 | 0.3 |
R391A | DNA base contact | 118 ± 14.8 | 43.7 | 86.0 ± 16.8 | 14.6 |
R394A | DNA base contact | 2757 ± 627 | 1021 | ND | ND |
Y395F | DNA base contact | 2.3 ± 0.5 | 0.9 | 13.5 ± 10.5 | 2.3 |
Y396F | DNA backbone contact | 26390 ± 9349 | 9774.1 | ||
Y397F | DNA backbone contact | NA | NA | ||
K404A | DNA backbone contact | NA | NA | ||
S334E | Phosphoserine mimic | 8.9 ± 3.2 | 3.3 | 9.4 ± 5.1 | 1.6 |
WT (phosphorylated) | PKA-phosphorylated Ser-334 | 521 ± 455 | 193 | ||
C416S | Abrogation of disulfides | 4.6 ± 0.6 | 1.7 | 2.6 ± 0.6 | 0.4 |
WT dimer | Disulfide-linked dimeric WT ETV1 | 195 ± 148 | 72.2 | 802 ± 164 | 136 |
WT dimer (TCEP reduced) | Dimeric WT ETV1, reduced | 11.2 ± 2.6 | 4.1 | 2.6 ± 0.4 | 0.4 |
WT dimer (9:1 GSH:GSSG) | Dimeric WT ETV1, reduced | 171 ± 23 | 29 | ||
WT dimer (1:9 GSH:GSSG) | Dimeric WT ETV1, reduced | 272 ± 30 | 47 | ||
Etv4 WT (reduced) | Wild type Ets domain, reduced | 3.4 ± 0.66 | 1 | ||
Etv4 WT (oxidized) | Disulfide-linked dimeric WT ETV4 | 148 c ± 35 | 44 | ||
Etv5 WT (reduced) | Wild type Ets, reduced | 11.6 ± 1.1 | 1 | ||
Etv5 WT (oxidized) | Disulfide-linked dimeric WT ETV5 | 790 ± 610c | 68 |
a Kd ± S.E.
b Fold increase in Kd value compared with the corresponding wild type.
c Estimated, due to binding at regression analysis threshold.